''T'' allele showed a statistically significant increased association with the risk of glioma (0.012) [R].
''C'' allele is associated with both decreased controlled ovarian hyperstimulation (COH) response and ovarian hyperstimulation syndrome (OHSS) risk (unadjusted OR = 0.10; P = 0.031) [R].
''T'' allele might significantly elevate the the risk of astrocytomas. TT genotype was found to be significantly associated with susceptibility of astrocytomas only in the grade III-IV subgroup [R].
Advanced hepatocellular carcinoma patients with the TT genotype were significantly associated with a better response and longer time to progression (TTP) (5.8 vs 4.5 months, P=0.016) [R].